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ABSTRACT
EFFECT OF TART CHERRY CONCENTRATE ON
PAIN, INFLAMMATION, AND STRENGTH
Natasha Kirkbride, MS
School of Health Studies
Northern Illinois University, 2018
Dr. Judith Lukaszuk, Director
The purpose of this double-blinded, randomized control study was to assess the impact of
tart cherry concentrate on pain, inflammation, and strength in resistance-trained males (n = 24).
Specifically, it analyzed the impact of tart cherry supplementation following an eccentric
exercise protocol without the use of NSAIDs. Participants received their supplementation of
either tart cherry concentrate (TC) or the placebo (PL) to consume over 8 consecutive days.
Participants supplemented twice daily with either the TC concentrate (one ounce of concentrate
mixed with water) or the placebo. On day 5 of the study, participants completed an eccentric
knee extension exercise with their right leg. Blood samples, maximum voluntary contraction
(MVC), and pain were assessed at baseline, 48 hours and 72 hours after the eccentric exercise.
Pain was measured using the Visual Analog Scale (VAS). Inflammatory markers
included SAA and CRP. Strength was assessed through MVC. The results of this study indicated
there were no favorable significant differences in pain, inflammation or strength between groups
or over time (p > 0.05). Future research should target the mechanism of action of tart cherries in
order to better understand the potential protective effect on muscle damage.
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CHAPTER 1
INTRODUCTION
Hundreds of thousands of athletes train vigorously every day, whether competitively, or
recreationally. The consistent breakdown of muscle calls for additional nutrients to promote
muscle anabolism. A combination of the need to accelerate muscle recovery and increase
nutrients to improve muscle recovery prompts the idea of using an antioxidant to assist in muscle
recovery. Due to strenuous activity induced by exercise muscle soreness, inflammation and pain
occur. Currently, one of the most accepted practices among athletes is NSAID use. However,
despite the fact that NSAIDs decrease muscle soreness and inflammation, Mikkelsen et al.
(2009) showed that NSAID use negatively affects satellite cell production after eccentric
exercise. Satellite cell development is essential in repairing micro-muscle tears following
resistance exercise.1 These findings suggest NSAID use may blunt the muscle’s ability to
properly repair DOMS related micro-muscle tears. This, in turn, would negatively affect strength
and power training adaptations.
Tart cherry juice has numerous benefits that lend its use to be optimal for assisting in
sports performance. It has a high antioxidant potential as measured by laboratory tests and
contains a number of compounds that fight free radicals.2-4 It has shown to decrease muscle
soreness, improve strength following exercise, and decrease inflammatory markers.4-9 Not only is
there evidence for enhanced sports performance, but it has shown to decrease fat, sugar, and
insulin levels in the blood, providing beneficial metabolic effects.10 The antioxidant property
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may also mitigate oxidative stress following exercise in the elderly. The benefits of TC (tart
cherries) provide a strong basis for the use in sports nutrition. TC supplementation has been
studied in athletics, specifically among runners,4 non-resistance trained males,6 water polo
players,12 professional male soccer players8 and two studies assessed the impact on resistancetrained males5,9. By utilizing an eccentric protocol, the functional recovery of resistance training
can be assessed. To our knowledge only two studies have assessed the effects of pain and
inflammation in lower extremities (knee extension), but one of the studies did not instruct
subjects to restrict NSAIDs for the duration of the study.5 Since NSAID use blunts muscle
strength, resistance-trained individuals are the population of interest. Due to a number of
discrepancies, the current tart cherry research is inadequate to demonstrate the effect of on
performance in resistance-trained athletes. Therefore, this study aimed to examine a natural
alternative to NSAIDs by creating an inflamed environment to evaluate the effect of tart cherries
on pain, inflammation, and strength.
Statement of the Research Problem
A large number of athletes from recreational to competitive have a need to decrease pain,
inflammation, and strength caused by resistance training. Due to this need, many turn to NSAID
consumption. Therefore, there is a need for quality research to evaluate a natural source to
attenuate those markers for those athletes who may be interested. Tart cherries have emerged as a
means to assist markers of muscle damage. The purpose of this randomized, double-blind,
placebo-controlled, experimental design was to determine the effect of 8-day supplementation of
TC concentrate on pain, inflammation, and strength. Tart cherry concentrate will significantly
attenuate inflammation, pain, and strength in resistance-trained individuals versus a placebo.
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The Independent Variable
Identification of the Independent Variable
Tart Cherry Concentrate (TC): 100% tart cherry concentrate – King Orchards©
Placebo (PL): A beverage with similar taste and visual properties- Kool-Aid©

Nominal Definition
The nominal definition for TC supplementation consisted of a treatment group (TC)
supplementing twice a day (once in the morning and once in the afternoon) for eight days versus
consuming a placebo (PL) using the same supplementation period.

Tart cherry concentrate group (TC): subjects consumed 1 oz TC concentrate of a commercially
formulated product mixed with 4 oz of water, twice a day.

Placebo group (PL): subjects consumed 4 oz of a placebo drink with similar visual and taste
properties as the TC.

Operational Definition
Subjects were randomly assigned to the TC group or PL group. The placebo consisted of a
beverage with similar visual and taste properties. Upon assignment, subjects were given tart
cherry juice or placebo and instructed to consume two doses for eight days.
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The Dependent Variables
Dependent Variable: Pain
The dependent variable of pain was assessed through a Visual Analog Scale (VAS).

Nominal Definition
VAS is a reliable measure for acute pain with well-defined threshold. VAS is a continuous scale
comprised of a horizontal (HVAS) or vertical (VVAS) line, usually 10 centimeters (100 mm) in
length, anchored by two verbal descriptors, one for each symptom extreme. Pain intensity is
assessed with “no pain” (score of 0) and “pain as bad as it could be” or “worst imaginable pain”
(score of 100 [100-mm scale]). To avoid clustering of scores around a preferred numeric value,
numbers or verbal descriptors at intermediate points are not recommended.4, 13,14
Operational Definition
For the purposes of this study, subjects completed the VAS to assess pain on two separate days
(48 hours and 72 hours after the eccentric exercise).

Dependent Variable: Inflammation
The dependent variable of inflammation is based on the measurement of CRP and SAA levels.

Nominal Definition
Strenuous exercise has shown to dramatically increase the inflammatory response of C-reactive
protein (CRP).16 Serum amyloid A (SAA) is a highly conserved acute-phase protein, released in
response to inflammation or infection.17
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Operational Definition
Both CRP and SAA were based on detection ranges.

Dependent Variable: Strength
Strength was assessed through maximum voluntary contractions (MVC) through the
dynamometer.

Nominal Definition
Muscular strength refers to the maximal force (expressed in either Newtons or kg) that can be
generated by a specific muscle or muscle group. Static or isometric strength can be measured
conveniently using a variety of devices, including cable tensiometers and handgrip
dynamometers. In this study the CSMi Humac Norm dynamometer was used. Peak force
development in such tests is commonly referred to as maximum voluntary contractions.18
Operational Definition
On day one of the study, subjects completed 3 MVC, separated by 15 second rest. Each MVC
was held for 3 seconds. Subjects returned to the laboratory 48 hours and 72 hours post-exercise
and completed three leg-extension MVC. The average and peak of all 3 MVC was recorded.
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Research Questions and Hypotheses
Research Questions:
1. What is the effect of tart cherry concentrate on pain in resistance-trained individuals
completing eccentric muscle contractions?

2. What is the effect of tart cherry concentrate on inflammation in resistance-trained
individuals completing eccentric muscle contractions?

3. What is the effect of tart cherry concentrate on strength in resistance-trained individuals
completing eccentric muscle contractions?

Hypotheses:
1. Tart cherry concentrate will decrease pain following eccentric muscle contractions in the
tart cherry group compared to individuals consuming the placebo.

2. Tart cherry concentrate will decrease inflammatory markers, following eccentric muscle
contractions in the tart cherry group compared to individuals consuming the placebo.

3. Tart cherry concentrate will attenuate strength loss, following eccentric muscle
contractions in the tart cherry group compared to individuals consuming the placebo.
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Background and Significance
NSAIDS
Research has shown that millions of people, including athletes, use non-steroidal antiinflammatory drugs (NSAIDs) to help reduce pain and inflammation.19 The COX enzymes
(COX-1 and COX-2) produce prostaglandins that promote inflammation and pain, in response to
injury. Inhibition of these enzymes may reduce inflammation (if present) and pain, hence the use
of NSAIDs.20 However, studies have yielded inconsistent results in regards to the efficacy of
anti-inflammatory drugs on reducing muscle soreness from intense exercise. One study looked
at the effects of saffron versus indomethacin (NSAID) on DOMS post eccentric exercise. The
indomethacin experienced pain prior to 72 hours while the saffron group did not.21 Some studies
have shown improvements of muscle recovery22-24 and prevention of exercise-induced fatigue,25
while other studies have displayed opposite results.26-28 However, despite the fact that NSAIDs
decrease muscle soreness and inflammation, Mikkelsen et al. (2009) showed that NSAID use
negatively affects satellite cell production after eccentric exercise. Satellite cell development is
essential in repairing micro-muscle tears following resistance exercise.1 Although NSAID use
may attenuate pain, these findings imply NSAID use may prevent the muscle’s ability to
properly repair DOMS related micro-muscle tears. This, in turn, would negatively affect strength
and power training adaptations.

NSAID Use in Athletes and Side Effects
Studies show that 50% of World Cup Soccer players consumed NSAIDs during World
Cup tournaments. Also, during the Atlanta and Sydney Olympic games, NSAIDs use in all
athletes was 33% and 38%, respectively.29 Athletes use NSAIDs and have shown to use them for
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providing that the main reason for use was injury treatment and the only known adverse side
effect noted by majority of athletes was gastrointestinal complications.30 Additionally, research
has shown that 29% of college athletes consume NSAIDS as a preventative measure.31 Although
athletes use NSAIDs, its side affects involve the gastrointestinal tract, cardiovascular system,
kidneys and liver.32,33 Specifically, when NSAID doses were taken regularly for one month, the
relative risk bleeding in the upper gastrointestinal tract was much higher than in controls.32 These
findings demonstrate that NSAIDs are not an optimal solution for athletes seeking aid to their
soreness and assistance to their performance.

Tart Cherries
If athletes consume NSAIDs and supplements as a means to decrease pain and influence
performance, assessing an alternate route to assist those markers would be of high interest. Sweet
and tart cherries both contain high levels of antioxidants including melatonin, carotenoids,
hydroxycinnamates, and several flavonoid groups including anthocyanins, as well as the flavonol
quercetin.34

Anti-Inflammatory and Antioxidant Role
Tart cherries have anti-inflammatory and antioxidant properties. Anthocyanins are plant
pigments found mostly in the skin of plants and provide the color to many fruits and
vegetables.36 Research has shown that anthocyanin content in cherry juice and reduced cell
damage are correlated. One study assessed anthocyanin function of tart cherries in mice. The TC
increased the enzyme superoxide dismutase, a free radical scavenger, and glutathione peroxidase,
an enzyme important in the removal of hydrogen peroxide.2
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Tart cherries’ ability to fight oxidation has been examined by comparing its antioxidant
capacity to fruits. Using an ORAC (oxygen radical absorbance capacity) assay, the antioxidant
capacity showed a range from 1,145 to 1,916 µmol Trolox equivalents (TE)/100 g in tart
cherries.3 The values found in tart cherries are comparable to those found in some berry fruits,
strawberry, and are higher than in apple and kiwis.37

Antioxidant Mechanism
Reactive oxygen species (ROS) and reactive nitrogen species (RNS) are produced in
reaction to dietary xenobiotics, normal biochemical reactions in our body, and increased
exposure to the environment. The ROS and RNS create oxidative stress in different
pathophysiological conditions. The reported chemical evidence suggests that dietary antioxidants
help in disease prevention. The antioxidant compounds react in one-electron reactions with free
radicals in vivo/in vitro and prevent oxidative damage.38 Antioxidant activity can be categorized
into enzymatic or non-enzymatic. The breakdown and removal of free radicals into hydrogen
peroxide and then water is the progression of an enzymatic antioxidant. This process requires
cofactors such as zinc, copper, and iron. A non-enzymatic reaction works by interrupting free
radical chain reactions. A few examples of the non-enzymatic antioxidants are vitamin C,
vitamin E, plant polyphenol, carotenoids, and glutathione.39 This antioxidant function of tart
cherry juice is related to its anthocyanin content.

Exercise
Several studies have assessed the impact of TC from exercise induced soreness,
inflammation, oxidative stress, etc. Sports have included resistance-trained exercise,5,6,9

running,

4,7
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water polo, , and soccer players. In order to show the affect of TC on markers of

inflammation, pain and strength, a strenuous activity must catalyze the symptoms. Eccentric
exercises have been associated to morphological alterations of the muscle, such as myofibrillar
disruption, disturbance of the extracellular matrix, and an inflammatory reaction, which results in
delayed onset muscle soreness (DOMS) and muscle stiffness.40-42 An eccentric muscle
contraction is produced when the force applied to the muscle exceeds the momentary force
produced by the muscle and results in a lengthening action (i.e. work is done on the muscle).43
One of the most common results of eccentric exercises, often because it is an unaccustomed
activity, is the delayed onset of pain; this is usually accompanied by functional changes/damages
to muscle fibers.43 Because this study aimed to utilize a strenuous activity upon participants, an
eccentric exercise protocol was used in this study as the means to induce muscle soreness, pain
and inflammation.

Inflammatory markers: CRP and SAA
C-reactive protein (CRP) was one of two blood markers assessed in this study to
determine inflammation. CRP is an acute-phase reactant. Plasma CRP concentrations increases
rapidly and dramatically (100-fold or more) in response to tissue injury or inflammation.44
Previous studies assessing the impact of TC have used hs-CRP and CRP as markers of
inflammation following exercise. Howatson et al. used CRP, IL-6 and uric acid, assessing the
influence of TC juice on marathon runners. All markers were significantly reduced in the TC
juice group.4
Serum amyloid A (SAA) is a highly conserved acute-phase protein, produced by
hepatocytes released in response to inflammation or infection. Production of acute-phase SAA
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(A-SAA) is stimulated by proinflammatory cytokines, such as interleukin-6 (IL-6), Il-1, tumor
necrosis factor (TNF), interferon-γ, and transforming growth factor- (TGF-). The concentration
of A-SAA increases dramatically during acute inflammation and injury, reaching within 5-6
hours levels that are 1000-fold greater than normal.17 To our knowledge only one other study has
used SAA as a marker of inflammation in response to TC, however this study assessed TC and
its affect on horses,45 so the current study is the first to assess the attenuation of SAA using TC
on human body inflammation post-exercise.
Previous studies which showed supplementation success with tart cherry concentrates and
cultivar juice blends, prompted an increase in exercise-based research to prove beneficial effects
in mitigating muscle damage, oxidative stress, inflammation, and muscle pain providing
motivation to increase performance.4,8,9 This study was conducted to prompt resistance training
individuals to gravitate towards pursuing a natural, compound rather than synthetic to assist in
inflammation, pain and strength.
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CHAPTER II
REVIEW OF LITERATURE
Historically athletes participating in strenuous exercise have taken over the counter drugs
such as NSAIDs in order to attenuate their muscle soreness and fatigue. Although NSAIDs are
effective in attenuating muscle pain22-23 negative side affects associated with taking NSAIDs,
include increased rates of acute kidney injury33, GI bleeding,32 increase in arterial blood
pressure,46 increased risk of stroke and cardiovascular death.37 Tart cherries, specifically in the
form of concentrate have been shown to have effects similar to that of NSAIDs, without
detrimental health affects. The anthocyanin content in TC makes it a favorable substitute to
NSAID consumption. Anthocyanin is the key ingredient to the antioxidant property of TC. The
ROS and RNS, produced in response to normal biochemical reactions in our body and increased
exposure to the environment, create oxidative stress in different pathophysiological conditions.
The antioxidant role, demonstrated in TC, prevents and mitigates oxidative damage.11,46 The
means to induce muscle damage in current literature has ranged including cycling,56 running,4,7
and soccer.8 Few studies have been conducted using eccentric exercise to induce muscle damage
and to assess TC affect on resistance-trained individuals. This indicates a need to evaluate the
effect of TC utilizing an eccentric only exercise protocol and including resistance- trained
individuals.
Registered dietitians and other health professionals play an important role by keeping up
to date with evidence-based research in order to provide accurate and sound recommendations to
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individuals seeking treatment or prevention of muscle damage. The natural source of TC
inresponse to vigorous exercise makes it an ideal candidate for registered dietitians and health
professionals to consider. However, more research is still needed. Although the exact mechanism
of TC is unclear, its effect has been observed in several studies over the past decade. Some
studies have used TC juice4,6,7 and some have used TC concentrate.5,8,48 Both have shown
beneficial results. Inflammation, shown through some inflammatory markers, has decreased in
response to TC consumption.8,56 Strength 4-6,8 and pain5-7 has also shown to improve in several
studies as well. The purpose of this literature review is to examine the current research that has
evaluated the effect of TC on inflammation, strength and pain, as well as studies that have used
eccentric exercise.

Markers of Inflammation
Studies that have assessed the effect of cherries on inflammation have used various
markers to measure its impact. Howatson et al. used CRP, IL-6 and uric acid, assessing the
influence of TC juice on marathon runners. All markers were significantly reduced in the TC
juice group.4 Bowtell et al. used hs-CRP and nitrotyrosine, and found no significant changes over
time or between groups for those markers.5 McCormick et al. found no differences between TC
and placebo groups for inflammatory markers IL-6 and CRP. However this study found no
significant differences for any of the markers and indicated that TC juice may have minimal to
no effect on non-weight bearing sports, such as the water polo participants in the study.12
Bell et al. assessed the attenuation of TC concentrate on semi-professional male soccer
players. This double blind, placebo-controlled design used the Loughborough Intermittent
Shuttle Test. Markers of inflammation were IL-1-β, IL-6, TNF-α, and hs-CRP. There was a
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significant main effect for hs-CRP, however no significant group effect. TC significantly
attenuated IL-6 and showed significant interaction effects. The discrepancy between IL-6 and hsCRP suggest that research should further this area to identify the mechanism that solves the
difference in findings.8
The only study to conduct an assessment on the affect of TC concentrate on highintensity stochastic cycling included 16 well-trained cyclists. Blood samples were obtained and
analysis was conducted on IL-6, TNF-a, IL-8, IL-1-B, and hs-CRP. Significant differences were
found for hs-CRP across all time points and IL-6, both lower in the TC group compared to
placebo. No other markers showed significant differences.56 The results of hs-CRP agree with
previous research,4 but disagree with others.5,8,9
Levers et al. did not find any significant differences in resistance-trained males for any
inflammatory markers, using interleukin-1β, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12p70,
IL-13, tumor necrosis factor-α, interferon-γ, and granulocyte-macrophage colony-stimulating
factor GM-CSF.9
There are several discrepancies in the results of inflammatory markers, post TC
consumption. The current study uses CRP. Out of the two studies that did use hs-CRP, Bowtell
et al., did not exclude for NSAID consumption, which may have influenced hs-CRP. Bell et al.
used hs-CRP as a marker, but did not find differences between groups. However, the current
study will use CRP because it has been shown to be an accurate indicator in strenuous exercise
environments.16 Serum amyloid A (SAA), a total body inflammatory marker, was not used in
any of the studies that have assessed the effect of TC on inflammation. Though it has been
deemed a sensitive marker of inflammation, this study was the first study to assess SAA in
response to eccentric exercise, following TC consumption.
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Strength
To assess the attenuation of TC concentrate on strength, measurements were taken both
before and after the TC supplementation period. In Connolly et al., following three days of TC
juice supplementation, a bout of eccentric elbow flexion contractions was performed on the
fourth day of supplementation. Isometric elbow flexion strength, pain, muscle tenderness, and
relaxed elbow angle were recorded before and for four consecutive days after the eccentric
exercise. Connolly et al. showed isometric elbow flexion strength loss was significantly greater
in the placebo trial than the cherry juice trial.6 Howatson et al. showed similar results, following
TC juice consumption, isometric strength recovered significantly faster in the TC group than
placebo.4
Bowtell et al. showed that MVC force recovery was significantly faster after cherry juice
consumption than placebo consumption as well. However, it is important to note that this study
did not exclude for NSAID consumption.5 MVC was also superior 72 h post-exercise in the TC
group compared to placebo in the study assessing male soccer players.8

Pain
In addition to the variables of inflammation and strength, pain was assessed as well.
Research has shown the development of pain in the elbow flexors after eccentric exercise is
significantly different in the placebo and cherry juice trials.6 Bowtell et al., measured pain
pressure threshold to assess pain. There was a significant reduction in pain pressure threshold
after 24 and 48 hours of recovery from the exercise protocol, however there was no significant
difference between groups.5 Two studies assessing runners used the VAS (Visual Analog Scale)
to assess pain. Kuehl et al. included runners following a relay race and showed that the increase

in pain was significantly smaller in the cherry juice group compared with the placebo group.
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Conversely, no differences were found for DOMS, in marathon runners.4 A VAS was used to
assess pain in the current study.

Resistance Trained Individuals
Resistance training is a common means of exercise to increase muscle mass, to improve
sports performance, and for rehabilitation. To our knowledge, only three studies have assessed
the effect of TC on resistance-trained individuals.5,6,9 Connolly assessed the impact of TC juice
using a randomized, placebo controlled, crossover design focusing on upper extremities.
Participants included fourteen male college students, who had no upper extremity resistance
training over the past 3 months. Isometric elbow flexion strength, pain, muscle tenderness, and
relaxed elbow angle were recorded before and for four days (baseline, 24, 48, 72, and 96 hours)
after the eccentric exercise. Results showed strength loss and development of pain was
significantly greater in the placebo group than the cherry juice group.
These findings reveal there is a significant effect on strength loss and pain when
individuals with limited upper body strength consume tart cherry juice. Furthermore, this
indicates tart cherry juice has a protective effect by preserving muscle. Limitations of this study
include a small sample size. In addition, this study was completed on individuals who had “no
upper extremity strength training for the past 3 months”, which does not account for ADL that
may assist in arm strength (e.g type of job, house hold chores, etc). One of the main strengths in
the study was that it instructed participants to not consume NSAIDs nor to seek any other
treatment for any symptoms of muscle damage, and not to exercise their upper extremities during
the study.6

17
Connolly aimed to focus on individuals who had no upper extremity training within the
past three months to help eliminate upper extremity resistance-trained individuals. The current
study included resistance-trained individuals, who have been training for at least 6 months.
Although Connolly et al provided information in regards to pain, strength, and muscle soreness,
no blood samples were taken, so markers of inflammation were not assessed.6
Levers et al. conducted a randomized, double-blind, placebo-controlled study with a total
of 23 participants. Inclusion criteria comprised of participants involved in a resistance-training
program with regular squat exercise for at least six months prior to study recruitment. The
placebo and treatment group were matched based on back squat strength, age, body weight, and
fat free mass. This study utilized powdered tart cherries as the supplement form (480 g),
equivalent to 10.5 oz of TC juice, consumed once a day at breakfast. Participants supplemented
for 10 days up to 48 hours post-exercise. The exercise used to induce muscle damage was ten
sets of ten repetitions (non-eccentric) of a barbell back squat at 70 % 1- RM with 3-min recovery
between sets. Prior to all testing days, participants were asked to refrain from exercise and
NSAID use for 48 hours. Dietary intake was recorded, muscle soreness was measured through
pressure application, and anthropometrics and body composition was measured. Blood samples
were obtained to measure several markers, including markers of inflammation, protein, and fatty
acid metabolism.9
Results regarding perceptions of muscle soreness indicated a significant overall time
interaction and non-significant overall group by time effect. Significant TC group reductions
from pre-lift levels were found for AST and creatinine 48-h post-lift, bilirubin and ALT 60-min
and 48-h post-lift. Significant differences were found lowered in TC for serum and total protein
over time and smaller from pre-lift levels over time compared to placebo. No significant
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differences were found for isokinetic strength recovery, markers of mechanical damage,
physiological stress, and inflammatory or anti-inflammatory markers.9
This study was the first to use a powdered form of tart cherries rather than juice or
concentrate. Levers et al. showed that short-term supplementation is shown to be effective in
reducing muscle soreness, but not for inflammation and oxidative stress, displaying the need for
future research to target those variables of exercise- induced inflammation and oxidative stress.
Other studies that used hs-CRP and IL-6 as an inflammatory marker also showed no significant
differences with supplementation.5,8 Lever’s study implies the powdered tart cherry form of
supplementation may not attenuate markers of inflammation, strength recovery, or mechanical
damage and physiological stress. Limitations include the potential nutrition and hydration
differences between groups, which may have contributed to variability as a hemodynamic
marker or performance measure. Additionally, the NSAID restriction of 48-hours prior to the
study may not have been enough.
The final study related to resistance-training and TC supplementation was a randomized,
placebo controlled, crossover design, but focused on lower extremities. Bowtell et al. included
10 well-trained males who had participated in high-intensity intermittent sports and regularly
performed resistance training. Exclusion criteria included cardiorespiratory and neuromuscular
problems and acute knee/ankle injuries and pain. Participants completed two main trials, which
were separated by a two-week washout period, with alternate legs used in each trial. Participants
consumed 30 mL twice a day of each supplement (TC concentrate or placebo) for 7 d before and
48 h after exercise. Blood samples and knee extension maximum voluntary contractions (MVC)
were performed before, immediately after, and 24 and 48 h after the eccentric exercise. Muscle
soreness was measured through algometer. Serum was analyzed for creatine kinase (CK)

19
activity, nitrotyrosine, hs-CRP, total antioxidant capacity, and protein carbonyls (PC). Pressure
pain threshold was also recorded. Results showed that MVC force recovery was significantly
faster after TC consumption than placebo. Only serum CK and PC increased significantly from
baseline, peaking 24 h after exercise. The exercise-induced increase in CK activity was not
different between trials. However, both the percentage and absolute increase in PC was lower in
TC than in placebo. There was no significant change over time nor between trials on total serum
nitrotyrosine or hs-CRP or in serum total antioxidant capacity.5
This study indicates that knee extensor maximum isometric strength was enhanced after
consuming Montmorency cherries for seven days before and two days after an intensive knee
extensor resistance training session. Although no markers of muscle damage or inflammation
were positively affected by TC consumption, there was reduction in serum PC indicative of
reduced oxidative damage. Consumption of TC did not seem to be appropriate for providing a
protective effect, but that it will help assist functional recovery.5 The primary limitation to this
study was that participants had no instruction related to NSAIDs for the duration of the study.
This means results of inflammation, pain, and strength could be attributed to NSAID
consumption. It also included a small sample size (n = 10). The current study included a larger
sample size (n=24). Participants were instructed to restrict NSAIDs 48 hours prior to collecting
baseline data and they were asked to refrain from strenuous exercise, limiting activity to walking
and light biking, for the duration of the study.5

Eccentric Exercise
An eccentric exercise protocol was used to induce pain, strength loss, and inflammation
in the current study. Other studies have used an eccentric exercise regimen to induce similar

5,6,9

markers as well.
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For the exercise regimen, Connolly et al. used a modified curl apparatus for

the onset of DOMS using two sets of 20 repetitions maximal contractions of the elbow flexors.
Participants applied maximal resistance, while the researcher forced the elbow into full
extension. Participants performed the two sets of maximal eccentric contractions, with the
eccentric phase lasting about three seconds. A 12 second rest was allowed between actions.6
Bowtell et al. first had participants, complete a warm-up of three sets of five repetitions at
50% 1RM. Participants then completed 10 sets of 10 single-leg knee extensions at 80% of their
1RM with elongated eccentric phase (lasting 3 s); each set was separated by 2 min of rest. If
participants were unable to sustain the workload, weight was decreased by 10%, and this was
then matched during the second trial on the alternate leg. After completing the 10 sets,
participants were asked to repeat the three MVC, with the first performed immediately after the
last set; subsequently, each MVC was separated by 2 min of rest.5 This study followed a similar
eccentric exercise protocol as Bowtell et al.5
Kuehl et al. did not use an eccentric exercise protocol, but to induce and mimic damage
of eccentric exercise included participants running the Hood to Coast relay race. Relays included
12 runners who completed three segments each with distances ranging from 5.6 to 12.4 km. The
race expanded over two mountain ranges, providing opportunity for eccentric muscle damage
through the hilly course. Results indicated that upon completion of the race, increase in pain was
significantly smaller in the cherry juice group compared with the placebo group.7

Summary
While some studies have been conducted to show the attenuation of TC on pain,
inflammation, and strength, there is a need to show the impact of all three variables on
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resistance-trained males. Since NSAID use blunts muscle strength, resistance-trained individuals
are the population of interest. Due to a number of discrepancies, the current tart cherry research
is inadequate to demonstrate the effect on performance in resistance-trained athletes. Therefore,
this study’s goal was to examine a natural alternative to NSAIDs by creating an inflamed
environment to evaluate the effect of tart cherries on inflammation, pain, and strength.
Individuals who do not have adequate nutrition education may be consuming products that do
not aid their performance. The purpose of this study therefore was to assess the impact of the tart
cherry concentrate on pain, inflammation and strength in order to improve performance for
athletes in the future.
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CHAPTER III
METHODOLOGY
Participants
Twenty-six resistance-trained males aged18-29 participated in this study. One participant
dropped out and there was not enough plasma available for the other participant, so 24
participants completed the study. Subjects were recruited from Northern Illinois University’s
campus classes. Exclusion criteria was anyone who had any blood related conditions or
transmitted diseases, cardiorespiratory conditions, past or present knee injuries, or anyone who
had not been strength training for at least six months. All subjects were informed of the risks and
benefits associated with this investigation and were given written consent (Appendix A) to
participate in accordance with Northern Illinois’ Institutional Review Board and Institutional
Biosafety Committee (Appendix B).

Experimental Design
This study used a randomized, double-blind, placebo-controlled, experimental design.
Subjects were assigned a number and then through a computer random number generator were
randomly assigned to either the tart cherry concentrate (TC) or a placebo (PL) group.
Participants received-either 1 oz. of Montmorency TC concentrate (King Orchards©; Central
Lake, MI) mixed with 4 oz of water or an equivalent placebo (Black Cherry Kool-Aid) twice
daily for 8 consecutive days. Subjects reported to the kinesiology laboratory at NIU, on days
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one, five, seven and eight of the study. On day one, subjects reported to the laboratory for
assessment of pain (Visual Analog Scale), strength (CSMi Humac Norm 770 dynamometer,
Stoughton, MA, 2009) and baseline inflammation (blood samples). They received and consumed
their first dose of supplementation after their baseline testing in the morning and continued the
supplementation through the end of the study (days one-eight). They completed the eccentric
exercise on day five. On day seven (48 hours after supplementation), subjects reported to the
laboratory for assessment of pain, strength and inflammation (blood samples). This was repeated
on day eight (72 hours after the eccentric exercise protocol). The study concluded on day eight,
the follow-up testing of pain, inflammation, and strength (see Table 1).

Estimating Sample Size
A statistical analysis program called G*Power (3.1.9.3; Erdfelder, Faul, & Buchner,
2007) was used to determine a priori the minimum sample size needed given alpha = .05, power
= .80, the effect size anticipated = .25 (‘medium’), the number of groups (C and T) = 2, and the
noted measures (n= 3) over time (baseline, 48 h, 72 h). Based on this set up, ideally, a minimum
of n = 36 subjects is used to control for a type II error. However, most studies that utilized a
similar design have included between 9-23 participants.4-6, 8, 9, 12
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Table 1:
Study Timeline
Timeline

Protocol

Baseline Testing:
Day one

Anthropometrics (Ht, Wt, Body Comp)
Measure Strength (MVC)
Assess Pain (VAS)
Obtain blood samples- Inflammatory
Markers (CRP, SAA)
Random Assignment (TC or PL)

Supplementation:
Day 1-8

1 oz TC (+4 oz water) OR
4 oz PL
2x/day

Eccentric Exercise:
Day five

Knee Extension:
Right leg

Post-Exercise Testing:
48 h, 72 h
(Day seven, Day eight)

Pain Measurement (VAS)
Strength (MVC)
Obtain blood samples- Inflammatory
Markers (CRP, SAA)
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Procedure
Preliminary Screening
Prior to random assignment, subjects completed a blood questionnaire, a HHQ, and a
screening questionnaire (Appendix C). Screening questionnaires were distributed in the classes
and then were collected once complete. Individuals who qualified were contacted via e-mail.
Researchers instructed the subjects to not participate in any lower extremity exercises 48
hours prior to the start of the study and throughout the duration of the study. This included:
running, vigorous biking, lifting weights, hiking, etc. Moderate lower extremity exercises, such
as light biking and walking were permitted. Subjects were allowed to participate in upper
extremity exercises. Subjects were also requested to refrain from NSAID consumption 48 hours
prior to the study and not to seek any other treatment for any symptoms of muscle damage.
Lastly, subjects were asked to maintain their current diet.

Baseline Testing
Anthropometrics
Height, weight and body composition were obtained on day one of the study in Anderson
Hall. Weight, fat mass, body fat percent, fat mass, fat free mass, and body mass index (BMI)
were assessed using a bioelectrical impedance scale (Tanita 520 Arlington Heights, IL). Height
was measured using a wall-mounted stadiometer (Ayrton S-100 Prior Lake, MN).

Supplementation
TC concentrate or a PL identical in appearance and taste were measured and labeled by a
3rd party individual to ensure that the study remained double blind. Subjects received 1 ounce of
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TC concentrate mixed with 4 ounces of water or 4 ounces of black cherry Kool-aid as the PL
(twice daily) for 8 consecutive days (days 1-8).

Strength Protocol
Determination of 1-repetition max (RM), in order to measure strength using maximal
voluntary contraction (MVC), was conducted on day one. In order to determine 1-RM, the
protocol followed ACSM handbook of 1-RM (Balady, 2000). 1-RM is the maximal weight that
can be lifted once with correct lifting technique (Appendix D). 1-RM was measured on a knee
extension machine using the right leg only. Based off the weight the participant could lift, and
using the measurement of the knee to ankle of, a conversion from pounds to Newton- meters
(NM) was used. Participants then used their right leg for the assessment of MVC.
MVC assessed strength using the CSMi Humac Norm dyanamometer machine (CSMi
Humac Norm 770 dynamometer, Stoughton, MA, 2009). Subjects were each assigned to a
profile within the system. Subjects completed maximal isometric knee flexion at a 90 degree
angle to allow for the optimal length of the quadriceps femoris to produce maximal force. MVC
was averaged and the average of the three and peak strength was recorded. All data were
recorded in Newton-meters. The results were obtained from the dynamometer.

Pain
Participants were asked to rate their pain scale on the Visual Analog Scale (VAS) on the
day of baseline testing. Participants were given the 100 mm VAS and asked to make a mark on
the line which most described their level of pain with general mobility. The VAS used in this
study was marked with the anchors of “no pain” to “worst imaginable pain”.
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Blood Sampling: SAA and CRP
Blood was collected from a forearm vein by trained phlebotomists (Appendix E) between
10 am and noon, on days one, seven and eight. Blood samples were collected in two 5.0 mL tiger
tubes serum separator tubes. Once blood coagulated (usually within 10-20 minutes of being
drawn) samples were centrifuged (Compact Centrifuge Clay- Adams, Beckton Dickinson
Company) for 15 min at 3000 g to separate plasma from whole blood. Plasma was pipetted off
and stored in microcuvette tubes which were frozen at minus 20 degrees C until further analysis.
Samples were transported on ice to NIU Medical Laboratory Sciences department and stored in a
minus 20 Celsius freezer until further analyzed.
Serum samples were analyzed for SAA and CRP. Commercially available enzyme-linked
immunosorbent assay (ELISA) kits were used to measure the plasma concentrations for Creactive protein (CRP) and serum amyloid A (SAA). C-reactive protein samples (CRP) were
analyzed in triplicate using ELISA kits. Plasma concentrations of each marker were calculated
by comparison to a pre-established standard curve. Serum amyloid A was measured using
sandwich ELISA and concentrations of each marker was first established running a separate 7
point standard curve. Once the appropriate concentration was established SAA levels were
analyzed on a separate day.
Eccentric Exercise
On day five of the study, subjects completed the knee extension eccentric exercise
protocol. Eccentric training occurs when the muscle is forcibly lengthened or elongated. An
eccentric contraction results when the force produced inside the muscle is less than what is
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applied to the muscle externally and results in active lengthening of the muscle fibers under
some level of load.50 This protocol utilized the eccentric duration of 3 seconds and was as
follows:
This protocol follows the similar protocol of Bowtell et al.5 and also was reviewed by a
certified strength and conditioning specialist. Subjects began with a warm up of 3
minutes biking at moderate resistance. Subjects then completed a warm up of three sets
of five repetitions at 50% maximal effort, each separated by a 30-second rest period.
Subjects then completed 6 sets of single-leg knee extension starting at about 85% of their
1-RM with an elongated eccentric phase (lasting 5 s) to failure; each set was separated by
a 1-minute rest. (An exact 85% could not be obtained because the specific dynamometer
used does not increase by increments less than 25 NM). If subjects were unable to
maintain the workload, the load was decreased by 25 NM. If subjects exceeded 15
repetitions after the second set, the load was increased by 25 NM. Participants were told
to aim between 8-12 reps for sets 1-4 and 6-8 reps sets 5 and 6. Assistants were available
to assist in lifting the arm of the dynamometer for the concentric movement, only if the
participant was struggling to lift the arm. Participants were not assisted for the eccentric
phase. Participants rate of perceived exertion (RPE) was recorded after each set to ensure
an RPE between 16-17 by set 4 and to ensure an RPE of 18-20 sets 5 and 6; this
encouraged maximal effort. Subjects received verbal encouragement to perform to their
maximum potential throughout the exercise protocol5 (See Appendix F for knee
extension procedure on dynamometer).

Follow-up Testing
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Subjects reported back to the laboratory 48 h and 72 h post-exercise to measure MVC,
pain, and obtain blood samples. Subjects completed the warm up and then three MVC separated
by a 15-second rest. All tests using the Humac used the right leg. Subjects used the VAS to
assess pain, and trained phlebotomists collected blood samples.

Description of Instrument
Visual Analog Scale
The Visual Analog Scale (VAS) is a unidimensional measure of pain intensity, which has
been widely used in diverse adult populations (Appendix D) and has shown to have high
reliability.13 For pain intensity, the scale is most commonly anchored by “no pain” (score of 0)
and “pain as bad as it could be” or “worst imaginable pain” (score of 100 [100-mm scale]). In
this study, the descriptive words used as anchors were “no pain” and “worst imaginable pain”.
The pain VAS is self-reported by the participant. The respondent is asked to place a line
perpendicular to the VAS line at the point that represents their pain intensity. Using a ruler, the
score is determined by measuring the distance (mm) on the 10-cm line between the “no pain”
anchor and the patient's mark, providing a range of scores from 0–100. In this study, participants
were asked to report their level pain with general mobility (walking, sitting, standing).
Normative values have not been determined. In a study assessing the acute measurement
of the VAS among patients at two emergency departments, the summary intraclass correlation
coefficients for all paired VAS scores was 0.97 [95% CI = 0.96 to 0.98]. The Bland-Altman
analysis showed that 50% of the paired measurements were within 2 mm of one another, 90%
were within 9 mm, and 95% were within 16 mm. The paired measurements were more
reproducible at the extremes of pain intensity than at moderate levels of pain.13 Test–retest
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reliability has been shown to be good, but higher among literate (r = 0.94, P < 0.001) than
illiterate patients (r = 0.71, P < 0.001) before and after attending a rheumatology outpatient
clinic.51 Without a gold standard for pain, criterion validity has not been evaluated. For construct
validity, in patients with a variety of rheumatic diseases, the pain VAS has been shown to be
highly correlated with a 5-point verbal descriptive scale (“nil,” “mild,” “moderate,” “severe,”
and “very severe”) and a numeric rating scale (with response options from “no pain” to
“unbearable pain”), with correlations ranging from 0.71–0.78 and 0.62–0.91, respectively).52 The
correlation between vertical and horizontal orientations of the VAS is 0.99.53,54

Statistical Analysis
Descriptive statistics were used to assess anthropometric variables such as height, weight,
body composition, and age. This research design had two groups (TC and PL) and three
measures: Pain, Strength, and Inflammation taken over time (eight days). A Split Plot (Mixed)
ANOVA where the ‘Mixed’ or the ‘Split’ is the dependent variable measured over time (repeated
measure - within) x the groups (TC vs. PL - between) was conducted. In order to assess the
attenuation of TC on the measures of Pain, Strength, and Inflammation between groups, an
independent sample t-test was used. Using the Bonferroni correction method, an alpha level of <
0.004 was used for the independent samples t-test to correct for type I error. An alpha level of <
0.05 was used for all other analyses. SAS JMP Version 12.0 (Cary, NC) was used to run
statistical analyses.
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CHAPTER IV
RESULTS
Participant Characteristics
A total of 24 healthy, resistance-trained men between 18-29 years old completed this
study. Physical characteristics of the subjects can be found in Table 2. Descriptive statistics and
independent sample t-tests were used to provide the averages of anthropometrics. A one-way
ANOVA revealed no significant differences (p > 0.05) in anthropometric markers, including lean
muscle mass.
Table 2:
Physical Characteristics of Subjects
Tart Cherry
(n = 12)
Age (yr)
22.92 + .9

Placebo
(n = 12)
22.58 + .7

Ht (cm)

174.63 + 2.1

179.20 + 2.2

Wt (kg)

79.36 + 4.4

84.83 + 3.4

Lean Mass (kg)

66.24 + 3.1

70.06 + 2.4

Body Fat Mass (kg)

13.11 + 3.3

14.75+ 2.6

BMI

26.05+ 1.4

26.32 + .9

Body Fat %

15.59+ 2.9

16.81+ 2.3

(Mean + SE)
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Summary of Research Findings
Pain
A Split- Plot ANOVA indicated there was a statistically significant difference across the
main effect time period (p < 0.01), which accounted for 46% of the variance. Contrast tests
showed this was significant at all time points (p < 0.05). The perception of pain for both the TC
and PL group increased over time, however, an independent sample t-test indicated there were no
significant differences between groups (p > 0.05). Table 3 shows the average pain at baseline, 48
hours post-exercise and 72 hours post-exercise.

Table 3:
Visual Analog Scale (Pain) Measurement
Tart Cherry
Placebo
(n = 12)
(n = 12)
Pain B
4.25 + 2.2
2.67 + 1.2
Pain 48

32.25 + 7.5

28.67 + 7.5

Pain 72

23.42 + 7.3

17.83 + 5.2

(Mean + SE); VAS range: 0-100 mm
Markers of Inflammation
CRP
CRP samples were run in triplicate and showed exceptional test-retest reliability (<1%
difference) using sandwich ELISA. Split Plot ANOVA, or repeated measures, was used to
analyze blood markers of SAA and CRP over time.
From baseline (M= .62 mg/dL) to 48 hours post-exercise (M = .63 mg/dL), the mean
CRP remained stable and showed no significant changes in the TC group. The mean CRP in the
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TC group remained similar at 72- hours post-exercise as well (M = .60 mg/dL). The PL group
decreased from baseline to 48 hours post-exercise, then increased at 72 hours post-exercise (M =
.65, M = .42, M = .84 mg/dL), respectively. There was no statistically significant main effect

CRP (mg/dL)

over time between groups, (p > 0.05).

Figure 1: C- Reactive Protein

SAA
Samples were run in duplicate and showed exceptional test-retest reliability (<1%
difference) using sandwich ELISA. Overall, there was a significant difference between groups
over time from baseline to 48 hours post-exercise (p = 0.023). There was a statistically
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significant difference across the main effect time period, which accounted for 14% of the
variance. There was a statistically significant time interaction effect between the TC and PL
group in SAA over time. Within the PL group, there was a statistically significant decrease in
SAA over time, occurring between baseline to 48 hours post exercise and from baseline to 72
hours post exercise (p = 0.013 and p = 0.012) respectively. Interestingly, the baseline SAA level
in the PL group (M = 91.06, SE = 8.14) was higher than the TC group (M = 87.26, SE = 8.14),

SAA (mg/dL)

but this was not statistically significant.

A
Figure 2: Serum Amyloid A
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Strength
Table 4 reports the maximum voluntary contraction performance. Data were obtained in
newton-meters. An independent sample t-test was conducted to assess the differences between
groups in overall strength. Peak baseline strength, was not significantly different (p > 0.004)
between groups (M = 305.7, SD = 77.9). After completing the exercise protocol and consuming
the supplement for seven consecutive days, participants returned to the laboratory, 48 hours later
(day seven) and 72 hours later (day eight). A split-plot ANOVA indicated that there were no
significant differences between groups over time for both peak and average MVC.
Table 4:
Maximum Voluntary Contraction Performance
Tart Cherry
(n = 12)

Placebo
(n =12)

Peak Strength B

287.25 + 17.1

305.67 + 22.5

Peak Strength 48

263.72 + 16.7

287.08 + 27.2

Peak Strength 72

282.75 + 19.3

301.67 + 29.9

Average Strength B

265.08 + 16.5

280.75 + 21.4

Average Strength 48

240.63 + 14.9

263.42 + 27.0

Average Strength 72

258.17 + 17.5

278.50 + 30.2

(Mean + SE)

MVC (Newton- meters)
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Figure 3: Peak Maximum Voluntary Contraction
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CHAPTER V
DISCUSSION
This is one of the first studies to assess the impact of tart cherry concentrate on pain,
inflammation and strength on resistance-trained males. It was hypothesized that supplementing
with tart cherry concentrate for five consecutive days prior to an eccentric exercise and for the
subsequent three days would reduce perceptions of pain, makers of inflammation, and improve
strength recovery 48 hours and 72 hours post-exercise. The results of this study indicate that the
supplementation did not favorably affect perceptions of pain, markers of inflammation, or
strength performance.

Pain
It was hypothesized that the perception of pain would decrease following eccentric
muscle contractions in the tart cherry group compared to individuals consuming the placebo 48
hours and 72 hours post-exercise. However, the findings showed that there were no significant
differences between groups after exercise. Participants used the VAS, which has shown to have
high reliability of acute pain.13 However, one factor to consider in using the Visual Analog Scale
(VAS), is the participant’s perception of pain is a subjective measurement. One disadvantage
encountered with the VAS is that participants seemed to have difficulty finding the point on the
line that best applied to his current pain- this could be related to the fact that the VAS only has
two verbal anchors. In addition, participants that are strength-trained may have a higher tolerance
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for pain; therefore, the reported pain level would be less than their counterparts of other healthy
athletic individuals.
Other studies have shown similar results. Howatson et al. and Bowtell et al. also showed
no differences between the TC and PL group.4,5 Howatson et al. also used a VAS and Bowtell et
al. used pain pressure threshold, both subjective measurements. It was surprising that both of
these groups found no differences in pain over time, considering inflammatory markers
decreased in both studies. The current study’s findings are consistent with the inflammatory
results in that the supplement did not decrease muscle inflammation or pain.
In direct contrast, some studies have found that TC supplementation decreases pain.
Connolly et al., which used a 0-10 scale showed the increase in pain was significantly smaller in
the TC group compared with the PL group.6 Discrepancies are likely related to the differences in
amount and type of exercise in the studies as well as the subjective attribute of the measurement.

Markers of Inflammation
Inflammatory markers of CRP and SAA at 48 hours and 72 hours post-exercise were
consistent with each other. Both decreased 48 hours post-exercise and then increased 72 hours
post-exercise. The CRP and SAA data indicated that the inflammatory response to completing
eccentric exercise was not attenuated by consuming cherry juice. Both the strength and pain data
support this interpretation. The placebo group had a higher baseline SAA than the treatment
group. Surprisingly, however, 48 hours post-exercise, there was a statistically significant drop in
SAA in the PL group, as well as a significant difference between groups at 48 hours postexercise. This showed a significant time interaction effect between the TC and PL group in SAA
over time. This result indicated TC did not favorably reduce acute inflammation.
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Most studies assessing the effect of TC on markers of muscle damage after exercise
gathered data 24-hours and 48-hours post-exercise, except for Bell et al.8 and Connolly et al.6, so
we cannot determine how the TC supplementation assisted in recovery after 48 hours postexercise. Bell et al. found increases in inflammatory marker data after exercise for plasma IL‐8
and hs-CRP; however, there were no significant differences between groups. There was a
discrepancy between those two inflammatory markers and IL-6, however, which did show group
differences. The discrepancy between IL-6 and hs-CRP was significant especially since IL-6 is
implicated as a signaling molecule for the expression of hs-CRP.55, 56 This discrepancy was not
resolved in that study, so the researchers suggested that further work is needed to identify the
mechanism by which TC exerts its anti-inflammatory responses in response to strenuous
exercise.8
Levers et al. and Bowtell et al. only assessed its participants until 48 hours post-exercise
and neither found significant changes in any inflammatory markers over time between groups.9,5
Howatson et al., which also assessed makers of muscle damage until 48 hours post-exercise,
found that IL-6, CRP and uric acid were influenced by tart cherry consumption following a
marathon. However, there were discrepancies since CK, LDH and DOMS were not different
between the cherry juice and placebo groups.4
Rationale for differences between the current study and other studies may be due to
differences in the amount and type of exercise. It is possible the single-leg muscle exercise was
insufficient to produce a systemic inflammatory response. In addition, SAA levels are related to
BMI, waist circumference, %fat, subcutaneous abdominal fat, and sagittal diameter but not
visceral fat.57 In this study, the PL group had a higher BMI and % body fat, however this was not
significant between groups. One other possible explanation for the difference is related to a

40
limitation of this study in that the participants were not required to fast prior to obtaining blood
samples. However, fasting samples are not required for CRP.58

Strength
MVC was measured at baseline, 48 hours and 72 hours post-exercise. Both average and
peak torque was recorded. Results indicated that strength recovery after exercise was not
different between groups. This is consistent with the current study’s findings related to markers
of muscle damage but inconsistent with other studies.
Connolly et al. showed isometric elbow flexion strength loss was significantly greater in
the placebo group than the cherry juice group.6 Howatson et al. showed similar results; following
TC juice consumption, isometric strength recovered significantly faster in the TC than PL
group.4 MVC force recovery was significantly faster after cherry juice consumption than placebo
consumption, as shown by Bowtell et al. MVC was also superior 72 hours post-exercise in the
TC group compared to the placebo in the study assessing male soccer players.8
The only study that found similar results to the current study indicated no significant
differences in the group effect over time of isokinetic strength recovery work performed.
However a moderate to large Cohen’s d effect size was noted in the TC compared to PL for drop
in the 3-repetition summation of flexion, extension, and total work performed 60-min post lift.
Additionally, results from Lever et al. revealed a non-significant time interaction and nonsignificant group x time effect.9 Discrepancies in this study were attributed to variation in
intensity, duration and modality compared to the other studies.
Other possible reasons for differences between the current and other studies could be
related to insufficient effort put forth by the participant during MVC. Participants were instructed
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to complete MVC at 100% maximum efforts, after completing the warm-up. However, it is
possible participants did not exert 100% effort, which would affect results.

Strengths and Limitations
The strengths of this study revolve around the analysis of several variables related to
muscle damage, including, assessment of pain, inflammatory markers and performance. This
double blind experimental study design was also favorable for the goals of this study.
Furthermore, the sample size was larger than other comparable studies of similar design and
purpose. Lastly, this study aimed to take into account possible confounding variables through the
screening process and throughout the study design to prevent those factors from affecting the
study results.
This research study is not without its limitations, which should also be considered.
Firstly, participants were randomized into two groups using a computer randomization generator,
however, participants were not placebo-control matched. The randomization ideally accounts for
variability between groups, however analysis indicated the placebo group was stronger in lean
body mass by 5.8%. However, when comparing the right leg lean mass between groups, the mass
of the PL group did not significantly affect peak or average MVC. So regardless if groups were
placebo-control matched, this may not have affected the strength results.
Another limitation includes the use of self-reported data for several screening questions
and demographic variables. Participants self-reported on screening questions including past or
present knee injuries, strength training 2-3 days a week for the last 6 months, and regular
consumption of NSAIDs. However, in spite of this, previous studies support the use of selfreported data as differences between self-reported data for medical history and self-reported

anthropometrics were small.

59,60
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In addition, compliance with consuming all of the TC and PL

supplement was not guaranteed. Along with this, a 48 hr restriction of NSAID consumption prior
to each session could not be promised either, despite email reminders to continue to refrain from
NSAID consumption.
Furthermore, participants were not asked to control hydration and/or nutrition status in
the interest of making this study as generalizable as possible to the population of resistancetrained males. However, variability in nutrition/hydration status between groups may have
affected performance outcomes.
Lastly, an unexpected limitation arose when the sterile urine cups used to hold the
supplement and placebo beverages were found to have a faulty seal. Researchers were not able to
obtain alternate cups that would have been adequate in quantity for the participants. The research
team tried to troubleshoot the situation by sealing the top of the cups with parchment paper,
however the cups continued to leak once transferred to the laboratory. That being said, the
amount of tart cherry supplement determined to attenuate variables (2 oz/day) was likely not
consumed by participants.

Conclusion
This research aimed to examine a natural alternative to NSAIDs by creating an inflamed
environment to evaluate the effect of tart cherries on inflammation, pain, and strength. The
results of this study indicated that supplementing with tart cherry concentrate prior to an
eccentric exercise, does not provide a protective effect against muscle damage. Findings related
to pain, are consistent with some of the other studies that have assessed tart cherry concentrate in
relation to exercise.4, 5 The current findings indicated that there was a significant difference over
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time measured for pain; however this was not favorable for the TC group. Due to the
discrepancies in findings compared to other studies and aside from the limitations of this study,
the authors of this study believe that there is a gap in research related to the mechanism of action,
which is needed to better understand the protective effect of the supplement.

Recommendations for Future Studies
Although this research study did not indicate favorable evidence for consuming tart
cherries as a nutritional supplement, future research should target the mechanism of short-term
supplementation of TC and other phytochemical containing nutrition supplements on highintensity anaerobic exercise. Additional evidence for the mechanism of TC supplementation on
endurance exercise is also needed. Not only is there a need for future research, but there is a need
for education as well. Individuals who do not have adequate nutrition education may be
consuming products that do not aid their performance. As athletes and exercise enthusiasts alike
consume nutritional products, it is necessary for health care professionals to be educated on the
effect of existing nutrition supplements. Education should target health care professionals on the
use of nutritional supplements, like TC, in order to improve performance for athletes in the
future.
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CONSENT FORM:
The Effect of Tart Cherry Concentrate on Pain, Inflammation and Strength
You are being asked to take part in a research study the effect of tart cherries on pain,
inflammation and strength. We are asking you to take part because you are a resistance-trained
male between the ages of 18-29. Please read this form carefully and ask any questions you may
have before agreeing to take part in the study.
Purpose: The purpose of this study is to assess the effect of tart cherries on pain, inflammation
and strength. You must be a resistance-trained male between the ages of 18-29 and meet the
eligibility criteria as determined through a screening survey, blood questionnaire and healthy
history questionnaire. These questionnaires should take approximately
Procedure: If you agree to be in this study, on day 1 you will need to report to Anderson Hall to
obtain blood samples, determine 1-repetition max (RM) and will be given cherry juice.
Collection of blood samples involves collection of intravenous blood sample collected by a
trained phlebotomist. You will be randomly assigned to consume 8 oz of a tart cherry beverage
or visually similar placebo two times a day (once in the morning and once in the afternoon) for 8
days. On day 5, you will need to report to the laboratory for an exercise protocol. After
consuming the cherry juice for 8 days, you will need to report to the laboratory 48 hours and 72
hours after consuming the beverage, for assessment of pain, obtaining blood samples and
measuring strength, as described below.
Obtaining blood samples: The blood will be drawn by putting a needle into a vein in your arm.
About 11.5 mL of blood will be collected. This will take about five minutes. This will occur for a
total of three times: Day 1, Day 7 and Day 9 of the study.
Determine 1-RM: You will be asked to complete a light warm up for 5 minutes on a bike, and
then complete a warm up of knee extension of 5-10 reps at 40-60% perceived maximum. After a
1-minute rest, 3-5 reps at 60-80% perceived maximum will be completed. After adding a small
amount of weight, the participant will complete a 1-RM. If the lift is successful, a rest period of
3-5 minutes will be provided. The goal is to find the 1-RM within 3-5 maximal efforts. This
should take about 15 minutes.
Exercise: This will include an eccentric exercise protocol that will involve a warm up of three
sets of five repetitions at 50% 1RM, each separated by a 2-minute rest period. Participants will
then complete three-knee extension maximum voluntary contractions (MVC) at 90o knee flexion
angle, separated by 2 minute rest. Participants will then complete 10 sets of 10 single-leg knee
extension at 80% of their 1RM with an eccentric phase lasting 3 s; each set will be separated by
2 min of rest. If participants are unable to maintain the workload, the load will be decreased by
10%. After completing the 10 sets, participants will be asked to complete three MVC, with the
first performed immediately after the last set; thereafter, each MVC will be separated by 2 min of
rest. Participants will receive verbal encouragement to perform to their maximum potential
throughout the exercise protocol. This should take about 20 minutes.
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Follow-up (48h and 72 h post-supplementation- Day 7 and Day 9): Report to Anderson Hall to
obtain blood samples (11.5 mL each time), measure strength through maximum voluntary
contractions (measured through knee-extensions on the dynamometer), and measure pain
(through a Visual Scale). This should take about 20 minutes.
Risks and benefits:
There is the risk that you may be sore after the exercise on day 5. Additionally, the needle stick
may hurt when obtaining blood. There is a small risk of bruising, fainting and infection. The
benefit to you will be your name entered into the raffle for a drawing of a gift card.
Compensation: You may earn extra credit if you are taking a class that offers credit for research
studies. The class instructor will assign credit according to class policy.
You will also be entered in a raffle to win one of five $20 gift cards.
Your answers will be confidential. The records of this study will be kept private. In any sort of
report we make public we will not include any information that will make it possible to identify
you. Research records will be kept in a locked file; only the researchers will have access to the
records.
Taking part is voluntary: Taking part in this study is completely voluntary. If you decide to
take part, you are free to withdraw at any time.
If you have questions: The researchers conducting this study are Natasha Kirkbride and Dr.
Judith Lukaszuk. Please ask any questions you have now. If you have questions later, you may
contact Natasha Kirkbride at z1805457@students.niu.edu or at 419-377-8516. You can reach Dr.
Lukaszuk at jmlukaszuk@niu.edu. You will be given a copy of this form to keep for your
records.
Statement of Consent: I have read the above information, and have received answers to any
questions I asked. I consent to take part in the study.
I understand that if I wish further information regarding my rights as a research subject, I may
contact the Office of Research Compliance at Northern Illinois University at (815) 753-8588.
Your Signature ___________________________________ Date__________________
Your Name (printed)
______________________________________________________________________
This consent form will be kept by the researcher for at least one year beyond the end of the study.
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Screening Survey (with Answers)
This survey will use the term strength train defined as a method of improving
muscular strength by gradually increasing the ability to resist force through the use
of free weights, machines, or the person's own body weight.
1. Are you a male student between the ages of 18-29?
- Yes
- No
2. Do you strength train at least 2-3 times a week?
- Yes
- No
3. Have you been consecutively strength training for six months or more (with less than one
month throughout of not strength training)?
- Yes
- No
4. Do you complete eccentric training on a regular basis?
Eccentric training defined: occurs when the muscle is forcibly lengthened or elongated.
An eccentric contraction results when the force produced inside the muscle is less than
what is applied to the muscle externally and results in active lengthening of the muscle
fibers under some level of load.
- Yes
- No
5. Do you have any cardiorespiratory conditions that prevent your daily living activities?
- Yes
- No
6. Do you have any lower extremity injuries (past or present) that impair your ability to
exercise?
- Yes
- No
7. Do you have knee (patellofemoral) pain?
- Yes
- No
8. Are you allergic to tart cherry juice or any cherry components (e.g. polyphenols,
anthocyanins, anthocyanidins)?
- Yes
- No
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9. Are you currently taking NSAIDs (anti-inflammatory) medication?
- Yes
- No
10. Are you currently consuming fish oil?
- Yes
- No
11. Are you currently consuming a Vitamin E supplement?
- Yes
- No
12. Are you right hand dominant?
- Yes
- No
13. Please provide an email address to be contacted by, should you qualify to be included in
this study:
__________________________________________________________________
Thank you for taking the time to complete this survey. You will be contacted if you qualify to be
included in this research study.

*Bolded= Eligibility

59
Health/Blood Questionnaire
Name:

Date:

Please answer the following by checking YES or NOYES NO
Have you ever had a bleeding condition or a blood disease?
Do you have Sickle Cell Anemia, or any other blood conditions?
Have you ever had liver disease, viral hepatitis, or a positive test for hepatitis?
Have you ever had malaria?
Have you ever had, or come into contact with persons possessing a sexuallytransmitted disease?
In the past 12 months have you had a tattoo applied, ear or skin piercing, accidental
needlestick, or
come into contact with anyone else's blood?
Have you ever used needles to take drugs, steroids, or anything else not prescribed
by your doctor?
In the past 12 months, have you had sexual intercourse with anyone who has ever used
needles to
take drugs, steroids, or anything else not prescribed by their doctor?
Have you ever had a positive test for the HIV/AIDS virus?
In the past 12 months, have you had sexual intercourse with anyone who has
HIV/AIDS or has had a positive test for the HIV/AIDS virus?
*All subjects have the right to not complete the form if they chose but they will be excluded for
safety reasons.
*If a subject answer YES but chooses not to disclose more information they will be excluded for
safety reasons.
I have read, understood, and completed this questionnaire. Any questions I had were answered to
my full satisfaction.
Name(Print)Signature-

Date-

60
Health History Questionnaire
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Determination of 1-RM:
1. Participants will complete a light warm-up of 5 minutes of biking.
2. Participants will then perform a light warm-up of 5-10 reps at 40-60% perceived
maximum.
3. Following a 1-minute rest with light stretching, the subject will complete 3-5 reps at 6080% of perceived maximum.
4. The subject should be close to a perceived 1-RM in step 2. A small amount of weight is
added, and a 1-RM lift is attempted. If the lift is successful, a rest period of 3-5 minutes
will be provided. The goal is to find the 1-RM within 3-5 maximal efforts. The process of
titrating the increase in weight up to a true 1-RM can be improved by prior
familiarization sessions that allow approximation of the 1-RM. Clear communication
with the subject is needed to facilitate determination of the 1-RM. This process will be
continued until a failed attempt occurs.
5. The 1-RM will be reported as the weight of the last successfully completed lift. (Balady,
2000)
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Visual Analog Scale:
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Venipuncture Procedure:
1. Identify the patient. Always ask the patient to state full name.
2. Assemble your supplies.
3. For multiple specimen collection of whole blood, serum and/or plasma use the following
order for collecting several specimens during a single venipuncture:
Note: manufacturers may use different colors for caps. Check the label for additive.

4.
5.
6.
7.

8.

9.

a. Blood culture: use protocol for filling bottles or use a syringe
b. Serum: no Additive-plain red cap or gold cap with separator gel
c. Chemistry tests: sodium heparin or lithium heparin- light freen cap or plasma
separator tube with separation gel.
d. Hemotology tests: EDTA-lavender cap
e. Coagulation tests; sofium citrate-light blue cap
Reassure and position the patient. The arm should be supported.
Apply the tourniquet and have the patient make a fist.
The tourniquet should not stop blood flow in the veins for more than 1 minute before the
blood is drawn because this causes hemoconcentration.
Select the venipuncture site. The median cubital and cephalic veins are used most
frequently.
Clean the venipuncture site with an alcohol pad, making one smooth circular pass of the
venipuncture site. Allow the skin to dry to prevent hemolysis of the specimen and to
prevent the patient form having a burning sensation when the venipuncture us performed.
Do not touch the vein site after cleaning it (or cleanse your finger tip as well).
Near the venipuncture site, use your thumb to draw the skin tight. With needle bevel
facing up, line up the needle with the vein. Penetrate the skin in a quick and smooth
motion,. Hold the vacutainer holder with one hand and push the tubes on wit the other
hand. Enter the vein at an angle of approximately 15-30 degrees.
Label the tube with the patients name after the sample is collected.
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Knee Extension Procedure:

Isokinetics
As explained in the Computer Sports Medicine Inc (CSMI) manual, “Isokinetics describes a
process in which a body segment accelerates to achieve a preselected fixed speed against an
accommodating resistance. No matter how much force is exerted by the patient, segment velocity
will not exceed the pre-selected speed. As torque is produced in an attempt to overcome the preselected speed, the resistance varies to exactly match the force applied at every point in the range
of motion.” The CSMI isokinetic testing has shown to be accurate, objective, reproducible and
safe. It has commonly been used in rehabilitation for areas including shoulder, elbow, forearm,
wrist, hip, knew, ankle, and back testing. As the patient reduces force output either because of
pain or weakness, there is an immediate reduction of resistance. This function is key to this study
because of the corresponding measurements that will be obtained through the dynamometer.
(CSMI, 2006)
Biomechanical Considerations
According to the CSMI, the knee is the easiest to test on the CSMI Norm System. Only one of
the major knee extensors is a two-joint muscle with an origin above the hip joint. Studies have
indicated that the positioning of the knee test creates maximum flexor and extensor forces with a
high level of reproducibility.
The test speed may be affected by the degree of hyperextension of the joint. Slow test speeds do
not elicit hyperextension, however higher test speeds “the inertia of the limb tends to help the
contracting muscles overcome the passive resistance of skin, fascia, and articular structures so
that significant hyperextension may occur.” The thigh may also slightly lift of the chair during
high speed testing. In light of these considerations however, the torque measurement is not
significantly affected, except during the first 1/8 second of a high-torque contraction. Even so,
clinical applications with a ±5° error relative to the position angle are accepted because of the
overall range of motion is quite accurate (CSMI, 2006).
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Knee Extension Set-up:
Reclining Chair Preparation
• Install Contralateral Limb Stabilizer in chair receiving tube #2 (if indicated.)
Dynamometer Preparation
• To install adapter on dyna input arm:
1. Secure Knee/Hip Pad on Knee/Hip Adapter with the pad offset toward the
dynamometer.
2. Insert adapter into long end of input arm and secure.
Position Patient
• Position patient appropriately on chair; provide Lumbar Cushion (if indicated.)
1. Have patient move forward or back on seat until the knee is just lightly touching
the chair-seat cushion.
2. Rotate Crank to adjust chair-back to meet patient’s back.
3. Secure Seat Belt and Shoulder Belts.
•
•
•
•
•

Chair-Seat Fore/Aft: Move and secure chair at an appropriate distance from dyna to
properly align knee axis of rotation with dyna axis.
Position Knee/Hip Pad on patient's leg and secure.
Secure Thigh Stabilizer Strap.
Test patient's ROM. Adjust set-up if required.
Record all scale values and click OK.
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Effect of Tart Cherry Concentrate on Pain, Inflammation and Strength
Debriefing Letter for Intervention Group Participants
You were randomly assigned to the intervention group and as such were provided a tart cherry
concentrate for the treatment. The tart cherry concentrate was mixed with 1 oz of water. The
color and taste properties were similar to the placebo group. Being in the tart cherry group, you
may have experienced some of the effect of being in the intervention group.
At the conclusion of the study, the participants in the control/placebo group will be un-blinded
and provided with the knowledge of the group they were assigned to as well.
Acknowledgement:
I, ________________________________, understand that I was a part of the intervention group
and received tart cherry concentrate.
Signature: ___________________________________________ Date: _____________
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Effect of Tart Cherry Concentrate on Pain, Inflammation and Strength
Debriefing Letter for Placebo Group Participants
You were randomly assigned to the control group and as such were provided a fruit juice with
similar color and taste properties as the tart cherry juice. Being in the control group, you most
likely did not experience any changes in pain, inflammation or strength due to the juice.
At the conclusion of the study, the participants in the treatment group will be un-blinded and
provided with the knowledge of the group they were assigned to as well.
Acknowledgement:
I, ________________________________, understand that I was a part of the placebo group and
received a placebo beverage for the duration of the study.
Signature: ___________________________________________ Date: _____________

